(Q53269527)

12 May 2018

title

Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis. (English)

1 reference

12 May 2018

Acute myeloid dendritic cell leukemia

1 reference

1 reference

1 reference

1 reference

Fanny Angelot-Delettre

1

1 reference

12 May 2018

Sabeha Biichle

2

1 reference

12 May 2018

Christophe Ferrand

3

1 reference

12 May 2018

Estelle Seilles

4

1 reference

12 May 2018

Béatrice Gaugler

5

1 reference

12 May 2018

Veronique Harrivel

6

1 reference

12 May 2018

Maria Alessandra Rosenthal-Allieri

7

1 reference

12 May 2018

Eric Deconinck

8

1 reference

12 May 2018

Philippe Saas

9

1 reference

12 May 2018

Francine Garnache-Ottou

10

1 reference

12 May 2018

publication date

6 June 2012

1 reference

12 May 2018

published in

Cytometry Part A

1 reference

12 May 2018

volume

81

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

page(s)

718-724

1 reference

12 May 2018

describes a project that uses

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

What is CD4+CD56+ malignancy and how should it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

The role of TCL1 in human T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Clinical and biologic features of CD4+CD56+ malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Opn: key regulator of pDC interferon production

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: practical recommendations and classifications.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Immunophenotypical, morphologic, and functional characterization of maturation-associated plasmacytoid dendritic cell subsets in normal adult human bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22072

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.22072

1 reference

12 May 2018

1 reference

12 May 2018